ArticleCancer science2017

Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors.

Hirokazu Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.